Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-11-17
Original SEC Filing: Click here

---

Webplus: SVA/20141117/6-K/2_EX-99.1/000.htm SEC Original: v394539_ex99-1.htm
Sinovac to Participate in Upcoming Investor Conferences BEIJING, September 2, 2014 — Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate in the following investor conferences in September: · Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt New York on September 9 and 10, 2014.

---

---

Webplus: SVA/20141117/6-K/3_EX-99.2/000.htm SEC Original: v394539_ex99-2.htm
Sinovac Announces New Presentation Time for Aegis Healthcare & Technology Conference BEIJING, September 5, 2014 — Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis Healthcare & Technology Conference, to be held at the Wynn Las Vegas on September 12, 2014. Management will present at 8:00 am PT.

---

---

Webplus: SVA/20141117/6-K/4_EX-99.3/000.htm SEC Original: v394539_ex99-3.htm
Sinovac to Participate in Jefferies 4th Annual Asia Summit BEIJING, Oct. 21, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will host investor meetings at the Jefferies 4th Annual Asia Summit, to be held at the Island Shangri-La Hotel in Hong Kong on October 29-30, 2014.

---

---

Webplus: SVA/20141117/6-K/5_EX-99.4/000.htm SEC Original: v394539_ex99-4.htm
Sinovac to Host Conference Call to Report Third Quarter 2014 Unaudited Financial Results BEIJING, November 5, 2014 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter, ended September 30, 2014, after market close on Friday, November 14, 2014 ET. The Company

---

---

Webplus: SVA/20141117/6-K/6_EX-99.5/000.htm SEC Original: v394539_ex99-5.htm
Sinovac Reports Unaudited Third Quarter Financial Results – Conference call scheduled for Monday, November 17, 2014 at 8:00 a.m. ET – BEIJING, Nov. 14, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced its unaudited financial results for the third quarter and nine months ended September 30, 2014. Third Quarter 2014

---

---

Webplus: SVA/20141117/6-K/1/000.htm SEC Original: v394539_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-11-17CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085